Zhenhe Suo - Concepedia

Author

Zhenhe Suo

University of Oslo

Also Known As

Z Suo, Z. H. Suo, Z. SUO, Z. Suo, Z.H. Suo, ZHENHE SUO, Zhen-He Suo, Zhen-he SUO, Zhen-he Suo, Zhenhe Suo

144

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

University of Oslo Oslo University Hospital First Affiliated Hospital of Zhengzhou University Zhengzhou University Norwegian Cancer Society

About

Zhenhe Suo is an author at University of Oslo specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	37	1.7K
2	Health Sciences	4	4	278
3	Natural Sciences	3	3	177
4	Engineering	1	1	17
5	Public Health	1	1	112

Zhenhe Suo

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival Zhenhe Suo, Bjørn Risberg, Mats G. Kalsson, The Journal of Pathology	2001	213
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets Qinghua Wu, Ragnhild A. Lothe, Terje Ahlquist, Molecular Cancer	2007	150
Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Qi Wang, Wei He, Changdong Lu, PubMed Esophageal CancerSquamous Cell CarcinomaPathologyCancer BiologyTumor Biology	2009	135
Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines Ping Wang, Quanli Gao, Zhenhe Suo, PLoS ONE	2013	132
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines Zhenyu Ji, Guanrui Yang, Vlada Vasovič, Journal of Photochemistry and Photobiology B Biology Protoporphyrin IxPhotochemistryPhotodynamic TherapyMechanistic PhotochemistryPhototoxicity	2006	123
USP7: Novel Drug Target in Cancer Therapy Zhiru Wang, Wen-Ting Kang, Yinghua You, Frontiers in Pharmacology Novel Drug TargetDrug TargetMolecular RegulationProteasomeMolecular Biology	2019	123
Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing Zhiru Wang, Wen-Ting Kang, Ouwen Li, Acta Pharmaceutica Sinica B	2020	121
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Elin M. Hennig, Zhenhe Suo, Steinar Thoresen, Breast Cancer Research and Treatment Cervical Cancer ManagementCervical CancerCervical HealthHuman Papillomavirus VaccinesMedicine	1999	112
Expression of Ephb2 and Ephb4 in breast carcinoma Qinghua Wu, Zhenhe Suo, Bjørn Risberg, Pathology & Oncology Research Tumor BiologyBreast OncologyMedicineBreast CancerBreast Carcinoma	2004	109
Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties Yuanyuan Ma, Dongming Liang, Jian Liu, PLoS ONE	2011	101

Page 1